ABBV

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

07/09 08:15 am

ProShares vs. iShares: Is NOBL or HDV the Better Dividend ETF for Investors?

07/09 07:34 am

Internationales Beratergremium für Handel und Investitionen in Shandong 2026 tagt in Jinan

07/09 02:56 am

Si è tenuta a Jinan la tavola rotonda 2026 dei consulenti internazionali per il commercio e gli investimenti dello Shandong

07/09 02:56 am

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

07/08 06:04 pm

Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026?

07/08 05:03 pm

ASDS Opens Registration for Annual Conference in San Diego

07/08 01:56 pm

The Dividend ETF Quietly Outperforming the S&P 500

07/07 05:30 am

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

07/06 01:59 pm

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?

07/05 09:15 am

Which Is the Better High Dividend ETF, iShares' HDV or Fidelity's FDVV?

07/04 05:05 pm

Exploring SKYRIZI's Exceptional Growth: Revenue and Market Expansion Analysis

07/03 07:57 am

Big Pharma Has a Case of Merger Mania

06/30 12:26 am

AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?

06/29 11:21 am

New study examines real-world switching patterns after patients transition from Humira to biosimilars

06/29 09:00 am

Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?

06/26 07:20 am

Here's How Much You'd Need to Invest in HDV to Generate $500 per Month in Dividends

06/23 02:02 pm

3 Monster Stocks to Hold for the Next 10 Years

06/23 06:05 am

AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?

06/22 06:36 pm

Should You Buy Moderna Before Aug. 5?

06/22 06:10 pm

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)

06/22 01:47 pm

5 Dividend Stocks to Buy and Hold Forever

06/22 06:15 am

Global Hyperpigmentation Treatment Market Size to Surpass USD 2.85 Billion by 2035, Growing at a 6.5% CAGR – SNS Insider

06/21 10:25 pm

AbbVie Declares Quarterly Dividend

06/18 04:05 pm

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

06/13 12:45 pm

Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock?

06/12 04:05 pm

AbbVie Says Nine-Year Data Reinforces Venetoclax Benefit In Leukemia Patients

06/12 10:30 am

AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend.

06/12 06:15 am

Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?

06/08 02:34 pm

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

06/08 09:00 am

State Street's Health Care ETF Tops Invesco's on Yield and Returns

06/02 07:10 am

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

06/01 02:19 pm

VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost

05/28 08:07 am

GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.

05/27 11:17 am

Prediction: These 2 Obesity Drug Stocks Could Double in 2026

05/26 04:04 am

The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech

05/22 09:15 pm

Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors

05/20 07:00 am

Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

05/19 01:00 pm

2 Stocks That Are Much Cheaper Than They Look

05/19 09:30 am

2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts

05/19 06:30 am

A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?

05/11 05:15 pm

Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape | DelveInsight

05/11 01:00 pm

What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress

05/10 01:37 pm

Want Reliable Dividend Income in May? These 2 Stocks Deliver

05/06 04:10 am

Want to Collect a High Dividend Every Month? Invest in These 3 Stocks

05/05 12:30 pm

AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook

05/04 04:30 pm

3 of the Best Dividend Stocks to Buy in May 2026

05/04 04:26 pm

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026

05/01 02:36 am

AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec

04/30 03:00 pm

AbbVie et adMare BioInnovations nomment RIME Therapeutics lauréat du Prix AbbVie des innovateurs en biotechnologies au Québec

04/30 03:00 pm